Explore / Peer-reviewed article
Peer-reviewed articleOpen access

Future paths in psychopharmacology
.

Thibaut F

Dialogues in clinical neuroscienceJan 1, 2019License: open accessFrance0 citations

Abstract

Drug development in psychiatry is gradually moving from serendipity to personalized medicine. Some promising paths will be reviewed in this issue.
.

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

MDMA

Keywords

VaccinePluripotent stem cellPsychopharmacologyPharmacogeneticsPrecision MedicinePsychedelic Drug
View paperFull text (PDF)

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.

Related research

ArticleMDMA

Chemsex drugs: More than ghb, mephedrone and methamphetamine?

Ramos J, Dolengevich H, Romerosa M +1

Europe PMC2021
ArticleMDMA

The effect of methamphetamine and 3,4-methylenedioxymethamphetamine on peripheral endocannabinoid concentrations: a study in healthy adults.

Deutsch A, Haggarty CJ, Petrie GN +4

Europe PMC2026
ArticleMDMA

Aesthetic mediation and lateral agency: Rethinking trauma and drug consumption in 'crisis ordinariness'.

Fomiatti R, Keane H, Nourse G +4

Europe PMC2026